Patents by Inventor Peter L. Pedersen

Peter L. Pedersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
    Patent number: 8119116
    Abstract: The present invention relates to methods of treating a cancerous tumor using selective inhibitors of ATP production. The present invention also relates to pharmaceutical preparations comprising such inhibitors and methods for administering them intraarterially directly to a tumor, as well as methods for identifying compositions that selectively inhibitor ATP production for use in the invention.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: February 21, 2012
    Assignee: John Hopkins University School of Medicine
    Inventors: Young Hee Ko, Jean-Francois Geschwind, Peter L. Pedersen
  • Therapeutics for Cancer using 3-Bromopyruvate and other Selective Inhibitors of ATP Production
    Publication number: 20090326068
    Abstract: The present invention relates to methods of treating a cancerous tumor using selective inhibitors of ATP production. The present invention also relates to pharmaceutical preparations comprising such inhibitors and methods for administering them intraarterially directly to a tumor, as well as methods for identifying compositions that selectively inhibitor ATP production for use in the invention.
    Type: Application
    Filed: January 16, 2009
    Publication date: December 31, 2009
    Applicant: The Johns Hopkins University
    Inventors: Young Hee Ko, Jean-Francois H. Geschwind, Peter L. Pedersen
  • Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
    Patent number: 7547673
    Abstract: The present invention relates to methods of treating a cancerous tumor using selective inhibitors of ATP production. The present invention also relates to pharmaceutical preparations comprising such inhibitors and methods for administering them intraarterially directly to a tumor, as well as methods for identifying compositions that selectively inhibitor ATP production for use in the invention.
    Type: Grant
    Filed: September 13, 2002
    Date of Patent: June 16, 2009
    Assignee: The Johns Hopkins University
    Inventors: Young He Ko, Jean-Francois H. Geschwind, Peter L. Pedersen
  • Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production
    Publication number: 20030087961
    Abstract: The present invention relates to methods of treating a cancerous tumor using selective inhibitors of ATP production. The present invention also relates to pharmaceutical preparations comprising such inhibitors and methods for administering them intraarterially directly to a tumor, as well as methods for identifying compositions that selectively inhibitor ATP production for use in the invention.
    Type: Application
    Filed: September 13, 2002
    Publication date: May 8, 2003
    Inventors: Young Hee Ko, Jean-Francois H. Geschwind, Peter L. Pedersen
  • Arrest of proliferation of highly glycolytic tumors
    Publication number: 20020068711
    Abstract: The present invention relates to a method of inhibiting the proliferation of tumor cells using antisense polynucleotides or oligonucleotides. Tumor cells having a highly glycolytic phenotype can be inhibited with an antisense molecule that hybridizes with a nucleic acid encoding a hexokinase. The present invention also relates to recombinant nucleic acid molecules useful for regulating transcription and translation and which can contain an antisense molecule. The present invention also relates to pharmaceutical preparations containing antisense molecules.
    Type: Application
    Filed: March 14, 2001
    Publication date: June 6, 2002
    Inventors: Peter L. Pedersen, Saroj P. Mathupala